ImmunityBio, Inc.
IBRX
$8.69
$0.485.79%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.70% | 21.55% | 31.22% | 3.33% | 74.65% |
| Total Depreciation and Amortization | -9.01% | -11.31% | -11.94% | -15.94% | -9.33% |
| Total Amortization of Deferred Charges | -98.00% | -- | -- | -- | -29.66% |
| Total Other Non-Cash Items | 108.68% | 149.33% | -22.20% | 196.17% | -118.37% |
| Change in Net Operating Assets | -32.89% | -22.71% | -203.56% | -466.02% | 57.89% |
| Cash from Operations | 17.34% | 30.23% | 20.53% | 19.70% | 26.14% |
| Capital Expenditure | 57.22% | 73.46% | -49.31% | 11.10% | 73.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 272.34% | -366.31% | 70.33% | 115.28% | 17.06% |
| Cash from Investing | 343.09% | -378.88% | 68.65% | 111.59% | 337.26% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | 45.45% | 80.95% | -- | 100.00% |
| Issuance of Common Stock | -50.11% | 992.13% | 230.08% | -98.44% | 1,051.35% |
| Repurchase of Common Stock | 26.53% | 49.50% | 35.08% | 68.92% | 48.59% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -48.66% | 1,013.59% | 16.06% | -109.60% | -46.68% |
| Foreign Exchange rate Adjustments | 171.43% | -609.09% | 533.33% | 74.36% | 74.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.13% | -323.45% | 2,727.02% | 37.49% | -63.87% |